You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
|
|---|---|
| Published in |
Frontiers in Pharmacology, June 2022
|
| DOI | 10.3389/fphar.2022.898062 |
| Pubmed ID | |
| Authors |
Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Michael Heinrich, Domingo A. Pascual-Figal, Shona Livingstone, Sajid Abaidullah |
X Demographics
The data shown below were collected from the profiles of 199 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 21 | 11% |
| France | 20 | 10% |
| United Kingdom | 8 | 4% |
| Poland | 6 | 3% |
| Japan | 5 | 3% |
| Canada | 4 | 2% |
| India | 3 | 2% |
| Pakistan | 2 | 1% |
| Spain | 2 | 1% |
| Other | 8 | 4% |
| Unknown | 120 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 182 | 91% |
| Practitioners (doctors, other healthcare professionals) | 11 | 6% |
| Scientists | 6 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 60 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 6 | 10% |
| Student > Bachelor | 6 | 10% |
| Unspecified | 4 | 7% |
| Researcher | 4 | 7% |
| Student > Ph. D. Student | 3 | 5% |
| Other | 6 | 10% |
| Unknown | 31 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
| Unspecified | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 4 | 7% |
| Engineering | 2 | 3% |
| Other | 0 | 0% |
| Unknown | 38 | 63% |
Attention Score in Context
This research output has an Altmetric Attention Score of 212. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2023.
All research outputs
#187,001
of 25,779,988 outputs
Outputs from Frontiers in Pharmacology
#76
of 20,006 outputs
Outputs of similar age
#5,627
of 450,368 outputs
Outputs of similar age from Frontiers in Pharmacology
#7
of 1,321 outputs
Altmetric has tracked 25,779,988 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,006 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,368 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 1,321 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.